Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic

{ 'indexed': { 'date-parts': [[2022, 10, 20]], 'date-time': '2022-10-20T05:00:32Z', 'timestamp': 1666242032657}, 'reference-count': 39, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 10, 1]], 'date-time': '2022-10-01T00:00:00Z', 'timestamp': 1664582400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.com', 'primary-care-diabetes.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 10]]}, 'DOI': '10.1016/j.pcd.2022.10.001', 'type': 'journal-article', 'created': {'date-parts': [[2022, 10, 4]], 'date-time': '2022-10-04T17:07:26Z', 'timestamp': 1664903246000}, 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health ' 'care in Catalonia during the first wave of the pandemic', 'prefix': '10.1016', 'author': [ {'given': 'Dan', 'family': 'Ouchi', 'sequence': 'first', 'affiliation': []}, { 'given': 'Carles', 'family': 'Vilaplana-Carnerero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vanessa', 'family': 'de Dios', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Giner-Soriano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rosa', 'family': 'Morros', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.pcd.2022.10.001_bib1', 'unstructured': 'European Centre for Disease Prevention and Control (ECDC), COVID-19 ' 'situation updates, 2022.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib2', 'unstructured': 'World health organization (WHO), Coronavirus disease 2019, 2022.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib3', 'doi-asserted-by': 'crossref', 'first-page': '1194', 'DOI': '10.1056/NEJMp2002125', 'article-title': 'Defining the epidemiology of Covid-19 — studies needed', 'volume': '382', 'author': 'Lipsitch', 'year': '2020', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib4', 'doi-asserted-by': 'crossref', 'first-page': '546', 'DOI': '10.1016/S2213-8587(20)30152-2', 'article-title': 'Practical recommendations for the management of diabetes in patients ' 'with COVID-19', 'volume': '8', 'author': 'Bornstein', 'year': '2020', 'journal-title': 'Lancet Diabetes Endocrinol.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib5', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.jdiacomp.2020.107723', 'article-title': 'Anti-inflammatory properties of antidiabetic drugs: a “promised land” ' 'in the COVID-19 era?', 'volume': '34', 'author': 'Katsiki', 'year': '2020', 'journal-title': 'J. Diabetes Its Complicat.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib6', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.3389/fcvm.2020.629933', 'article-title': 'Why Is COVID-19 more severe in patients with diabetes? the role of ' 'angiotensin-converting enzyme 2, endothelial dysfunction and the ' 'immunoinflammatory system', 'volume': '7', 'author': 'Roberts', 'year': '2021', 'journal-title': 'Front. Cardiovasc. Med.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib7', 'doi-asserted-by': 'crossref', 'first-page': '2441', 'DOI': '10.1056/NEJMoa2008975', 'article-title': 'Renin–Angiotensin–Aldosterone system inhibitors and risk of Covid-19', 'volume': '382', 'author': 'Reynolds', 'year': '2020', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib8', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.isci.2020.101400', 'article-title': 'The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the ' 'SARS-CoV-2 Spike', 'volume': '23', 'author': 'Li', 'year': '2020', 'journal-title': 'IScience'}, { 'key': '10.1016/j.pcd.2022.10.001_bib9', 'doi-asserted-by': 'crossref', 'DOI': '10.1177/2042018821996482', 'article-title': 'Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients ' 'with diabetes mellitus: an updated systematic review and meta-analysis', 'volume': '12', 'author': 'Pal', 'year': '2021', 'journal-title': 'Ther. Adv. Endocrinol. Metab.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib10', 'doi-asserted-by': 'crossref', 'first-page': '135', 'DOI': '10.1016/j.bbrc.2020.03.044', 'article-title': 'Single cell RNA sequencing of 13 human tissues identify cell types and ' 'receptors of human coronaviruses', 'volume': '526', 'author': 'Qi', 'year': '2020', 'journal-title': 'Biochem. Biophys. Res. Commun.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib11', 'doi-asserted-by': 'crossref', 'first-page': '3585', 'DOI': '10.1210/endo.136.8.7628397', 'article-title': 'Degradation of glucose-dependent insulinotropic polypeptide and ' 'truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl ' 'peptidase IV', 'volume': '136', 'author': 'Kieffer', 'year': '1995', 'journal-title': 'Endocrinology'}, { 'key': '10.1016/j.pcd.2022.10.001_bib12', 'doi-asserted-by': 'crossref', 'first-page': '779', 'DOI': '10.1007/s00592-020-01539-z', 'article-title': 'Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19', 'volume': '57', 'author': 'Solerte', 'year': '2020', 'journal-title': 'Acta Diabetol.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib13', 'doi-asserted-by': 'crossref', 'first-page': '423', 'DOI': '10.1016/j.diabet.2020.07.006', 'article-title': 'Metformin and COVID-19: from cellular mechanisms to reduced mortality', 'volume': '46', 'author': 'Scheen', 'year': '2020', 'journal-title': 'Diabetes Metab.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib14', 'doi-asserted-by': 'crossref', 'first-page': '894', 'DOI': '10.1016/j.tim.2021.03.004', 'article-title': 'Therapeutic potential of metformin in COVID-19: reasoning for its ' 'protective role', 'volume': '29', 'author': 'Samuel', 'year': '2021', 'journal-title': 'Trends Microbiol.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib15', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.4269/ajtmh.20-0375', 'article-title': 'Metformin treatment was associated with decreased mortality in COVID-19 ' 'patients with diabetes in a retrospective analysis', 'volume': '103', 'author': 'Luo', 'year': '2020', 'journal-title': 'Am. J. Trop. Med. Hyg.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib16', 'doi-asserted-by': 'crossref', 'first-page': '243', 'DOI': '10.1111/1753-0407.13135', 'article-title': 'The potential effects of clinical antidiabetic agents on SARS‐CoV‐2', 'volume': '13', 'author': 'Qu', 'year': '2021', 'journal-title': 'J. Diabetes'}, { 'key': '10.1016/j.pcd.2022.10.001_bib17', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1111/cob.12439', 'article-title': 'Glucagon‐like peptide‐1 receptor agonists in the era of COVID ‐19: ' 'Friend or foe?', 'volume': '11', 'author': 'Belančić', 'year': '2021', 'journal-title': 'Clin. Obes.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib18', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1210/endrev/bnaa011', 'article-title': 'Coronavirus infections and type 2 diabetes—shared pathways with ' 'therapeutic implications', 'volume': '41', 'author': 'Drucker', 'year': '2020', 'journal-title': 'Endocr. Rev.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib19', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fendo.2021.649525', 'article-title': 'COVID-19 and diabetes: understanding the interrelationship and risks ' 'for a severe course', 'volume': '12', 'author': 'Landstra', 'year': '2021', 'journal-title': 'Front. Endocrinol.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib20', 'doi-asserted-by': 'crossref', 'DOI': '10.1136/bmjdrc-2020-001343', 'article-title': 'Clinical characteristics and outcomes of patients with severe covid-19 ' 'with diabetes', 'volume': '8', 'author': 'Yan', 'year': '2020', 'journal-title': 'BMJ Open Diabetes Res. Care.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib21', 'doi-asserted-by': 'crossref', 'first-page': '867', 'DOI': '10.1007/s40618-020-01236-2', 'article-title': 'Prevalence and impact of diabetes among people infected with SARS-CoV-2', 'volume': '43', 'author': 'Fadini', 'year': '2020', 'journal-title': 'J. Endocrinol. Investig.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib23', 'doi-asserted-by': 'crossref', 'article-title': 'Data resource profile: the information system for research in primary ' 'care (SIDIAP)', 'author': 'Recalde', 'year': '2022', 'journal-title': 'Int. J. Epidemiol.', 'DOI': '10.1093/ije/dyac068'}, { 'key': '10.1016/j.pcd.2022.10.001_bib24', 'first-page': '1', 'article-title': 'Data resource profile: the information system for research in primary ' 'care (SIDIAP', 'author': 'Recalde', 'year': '2022', 'journal-title': 'Int. J. Epidemiol.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib25', 'author': 'WHO, ICD-10 Version: 2019', 'year': '2019', 'journal-title': 'Int. Stat. Classif. Dis. Relat. Health Probl. 10th Revis.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib26', 'unstructured': 'WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index ' '2022, (2022). https://www.whocc.no/atc_ddd_index/.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib27', 'unstructured': 'CatSalut. Servei Català de la Salut, Conjunt mínim bàsic de dades ' '(CMBD), (2022). ' 'http://catsalut.gencat.cat/ca/proveidors-professionals/registres-catalegs/registres/cmbd/.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib28', 'unstructured': 'Catalan Agency for Health Quality and Evaluation (AQuAS), Updated ' 'SARS-CoV-2 data, (2022). ' 'https://aquas.gencat.cat/ca/actualitat/ultimes-dades-coronavirus/index.html#googtrans(ca%7Cen).'}, { 'key': '10.1016/j.pcd.2022.10.001_bib29', 'unstructured': 'Departament de Salut Generalitat de Catalunya, COVID Data, (2022). ' 'https://dadescovid.cat/?lang=eng.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib30', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/jcm11082092', 'article-title': 'Diabetes does not increase the risk of hospitalization due to COVID-19 ' 'in patients aged 50 years or older in primary care—APHOSDIAB—COVID-19 ' 'multicenter study', 'volume': '11', 'author': 'Orozco-Beltrán', 'year': '2022', 'journal-title': 'J. Clin. Med.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib31', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2021.108977', 'article-title': 'The effect of metformin on mortality and severity in COVID-19 patients ' 'with diabetes mellitus', 'volume': '178', 'author': 'Yang', 'year': '2021', 'journal-title': 'Diabetes Res. Clin. Pract.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib32', 'first-page': '926', 'article-title': 'The association between antidiabetic agents and clinical outcomes of ' 'COVID-19 patients with diabetes: a bayesian network meta-analysis', 'volume': '0', 'author': 'Chen', 'year': '2022', 'journal-title': 'Front. Endocrinol.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib33', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.metabol.2022.155196', 'article-title': 'Preadmission use of antidiabetic medications and mortality among ' 'patients with COVID-19 having type 2 diabetes: a meta-analysis', 'volume': '131', 'author': 'Nguyen', 'year': '2022', 'journal-title': 'Metab.: Clin. Exp.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib34', 'doi-asserted-by': 'crossref', 'first-page': '1158', 'DOI': '10.3389/fendo.2021.708494', 'article-title': 'Mortality risk of antidiabetic agents for type 2 diabetes with ' 'COVID-19: a systematic review and meta-analysis', 'volume': '12', 'author': 'Kan', 'year': '2021', 'journal-title': 'Front. Endocrinol.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib35', 'article-title': 'DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: ' 'a meta-analysis', 'author': 'Yang', 'year': '2021', 'journal-title': 'PLoS One'}, { 'key': '10.1016/j.pcd.2022.10.001_bib36', 'doi-asserted-by': 'crossref', 'first-page': '904', 'DOI': '10.3803/EnM.2021.1048', 'article-title': 'Dipeptidyl peptidase-4 inhibitors and COVID-19-related deaths among ' 'patients with type 2 diabetes mellitus: a meta-analysis of ' 'observational studies', 'volume': '36', 'author': 'Patoulias', 'year': '2021', 'journal-title': 'Endocrinol. Metab.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib37', 'doi-asserted-by': 'crossref', 'first-page': '1399', 'DOI': '10.2337/dc20-0660', 'article-title': 'Clinical characteristics and outcomes of patients with diabetes and ' 'COVID-19 in association with glucose-lowering medication', 'volume': '43', 'author': 'Chen', 'year': '2020', 'journal-title': 'Diabetes Care'}, { 'key': '10.1016/j.pcd.2022.10.001_bib38', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.cmet.2020.11.014', 'article-title': 'Insulin treatment is associated with increased mortality in patients ' 'with COVID-19 and Type 2 diabetes', 'volume': '33', 'author': 'Yu', 'year': '2021', 'journal-title': 'Cell Metab.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib39', 'first-page': '82', 'article-title': 'Articles Risks of and risk factors for COVID-19 disease in people with ' 'diabetes: a cohort study of the total population of Scotland', 'volume': '9', 'author': 'Mcgurnaghan', 'year': '2021', 'journal-title': 'Www. Thelancet. Com. /Diabetes-Endocrinol.'}, { 'key': '10.1016/j.pcd.2022.10.001_bib40', 'first-page': '1', 'article-title': 'A novel method for COVID-19 diagnosis using artificial intelligence in ' 'chest X-ray images', 'volume': '9', 'author': 'Almalki', 'year': '2021', 'journal-title': 'Healthc. (Basel)'}], 'container-title': 'Primary Care Diabetes', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S175199182200167X?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S175199182200167X?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 10, 19]], 'date-time': '2022-10-19T23:10:11Z', 'timestamp': 1666221011000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S175199182200167X'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 10]]}, 'references-count': 39, 'alternative-id': ['S175199182200167X'], 'URL': 'http://dx.doi.org/10.1016/j.pcd.2022.10.001', 'relation': {}, 'ISSN': ['1751-9918'], 'subject': [ 'Nutrition and Dietetics', 'Endocrinology, Diabetes and Metabolism', 'Internal Medicine', 'Family Practice'], 'container-title-short': 'Primary Care Diabetes', 'published': {'date-parts': [[2022, 10]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study ' 'in primary health care in Catalonia during the first wave of the pandemic', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Primary Care Diabetes', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.pcd.2022.10.001', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2022 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights ' 'reserved.', 'name': 'copyright', 'label': 'Copyright'}]}